The Mingle-Mangle of Wnt Signaling and Extracellular Vesicles: Functional Implications for Heart Research
Julia Christina Gross
Laura Cecilia Zelarayán- 1Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany
- 2Developmental Biochemistry, University Medical Center Göttingen, Göttingen, Germany
- 3Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany
- 4Partner Site Göttingen, German Centre for Cardiovascular Research (DZHK), Göttingen, Germany
Wnt signaling is an important pathway in health and disease and a key regulator of stem cell maintenance, differentiation, and proliferation. During heart development, Wnt signaling controls specification, proliferation and differentiation of cardiovascular cells. In this regard, the role of activated Wnt signaling in cardiogenesis is well defined. However, the knowledge about signaling transmission has been challenged. Recently, the packaging of hydrophobic Wnt proteins on extracellular vesicles (EVs) has emerged as a mechanism to facilitate their extracellular spreading and their functioning as morphogens. EVs spread systemically and therefore can have pleiotropic effects on very different cell types. They are heavily studied in tumor biology where they affect tumor growth and vascularization and can serve as biomarkers in liquid biopsies. In this review we will highlight recent discoveries of factors involved in the release of Wnts on EVs and its potential implications in the communication between physiological and pathological heart cells.
Wnt Signaling Pathways Overview
Wnts are evolutionarily conserved, secreted glycosylated growth factors, which in humans are encoded by 19 different Wnt genes. There are more than 15 different Wnt receptors and co-receptors, including Frizzled (FZD1-10), LRP5 and 6, and ROR1/2 that are best described. Depending on their binding to receptors and downstream components, Wnt signaling has been classified into canonical (β-catenin-dependent) or non-canonical (β-catenin-independent) pathways. The β-catenin-independent pathways include Planar Cell Polarity (PCP) and Wnt–Ca2+ pathway [reviewed in (1)].
The β-catenin-dependent pathway is activated by binding of Wnts with FZDs and LRP5/6, and subsequent GSK3β inhibition, leading to stabilization of cytoplasmic β-catenin. Upon accumulation, β-catenin enters the nucleus binds to TCF (T cell factor)/LEF (lymphoid enhancer-binding factor) transcription factors and regulates the transcription of target genes. Additionally, β-catenin-independent Wnt pathways use different downstream signaling modules. The PCP signaling is activated via FZDs receptors with ROR1/2 and PTK7 as co-receptors, through a cascade of small GTPases RAC1, RHOA and JUN-N-terminal kinase (JNK) activation. This pathway leads to changes in cytoskeleton, cell polarity and activation of JNK-dependent transcription factors and their target genes [reviewed in (2)].
A second β-catenin-independent pathway is the Wnt–Ca2+pathway. Here, Wnts trigger FZD-mediated activation of heterotrimeric G proteins. This activates phospholipase C (PLC), diacyl-glycerol (DAG) and inositol-1,4,5-trisphosphate [Ins(1,4,5)P3] cascade triggering intracellular Ca2+-release and activation of effectors such as calmodulin-dependent kinase II (CAMKII), calcineurin and protein kinase C (PKC), which activate the transcriptional regulator nuclear factor associated with T cells (NFAT) (3).
In addition to Wnts, several inhibitors, such as Dickkopfs (DKK1-3), secreted Frizzled related proteins (SFRP1-5) and activators, such as R-Spondins (RSPO1-5) are similarly secreted and can regulate the amplitude and specificity of Wnt signaling at the extracellular level (4). Additionally, intracellular cytosolic and nuclear inhibitors fine-tune Wnt signaling.
Wnt Component Mobilization in Extracellular Vesicles
Currently, increasing evidences show the importance of different Wnt signaling branches and their crosstalk among different cell types. Secreted Wnts are lipidated and this hydrophobic moiety hinders them to freely move in the extracellular space. Different experimental proofs showed how their biochemical properties would fit to the idea of “diffusible” morphogens (5). Lipoprotein particles (6, 7), filopodia-surfing (8, 9) and transport on extracellular vesicles (10) were shown to confer biological Wnt activity in different systems [reviewed (11)]. “Extracellular vesicles (EVs)” is a term used for different sub-populations of membrane particles secreted from a plethora of cells into the extracellular space. Based on size and subcellular origin, they are discriminated into exosomes (50–100 nm), microvesicles (100–500 nm) and apoptotic bodies (>1000 nm) (12). Distinct proteins as well as lipid markers allow characterization of different types of EVs (13). CD9 or EMMPRIN are normally found in larger, plasma membrane-derived EVs, while components of the endosomal sorting complexes required for transport (ESCRT) machinery, such as Tsg101 and Alix are markers for the endosome-derived exosomes (14, 15). EVs are purified by differential ultracentrifugation, gel filtration or immunoprecipitation, while their size and composition are investigated by nanoparticles tracking, electron microscopy, immunoblotting and mass spectrometry. Standards for their purification and analysis have been defined and can help to increase reproducibility of EV studies (16). Currently, cell type-specific markers for EVs are missing.
Exosomes carrying Wnts were shown to play key roles under physiological conditions in different systems (17) (Table 1). The first evidence that Wnts might be released on membrane-bound structures came from studies of Drosophila Wnt, Wingless. In Drosophila, exosomes, containing the Wnt secretion factor Evi, transport Wnts across the Drosophila neural-muscular junctions (NMJ) and in the wing imaginal disc (10, 31, 32). Recently, a crosstalk was discovered in tooth development, activating Wnt/β-catenin signaling in mesenchymal cells via exosomal miRNA from epithelial cells (33).
Table 1. Recent studies about mechanisms and effects of Wnt release in mammalian systems
As EVs are detectable in the circulation, it was conceived that their activity spreads systemically. Indeed, under pathological conditions, their functionality has long-range activity influencing metastatic niches far away from their source [reviewed in (34)]. Further examples are: (1) Tethering of autocrine Wnt11 to fibroblast-derived exosomes to influence the migratory phenotype of breast cancer cells (29); (2) colorectal tumor cells signal to endothelial cells (EC) by HIFα-induced exosomal Wnt4 secretion, activating Wnt/β-catenin signaling to increase migration and proliferation of ECs (23). Although this work is focused on cancer cells, activation of HIFα upon hypoxia plays a role in cardiac stress (23) and might have similar effects on EC crosstalk in cardiovascular pathologies.
Implication and Caveats of the Wnt Signaling and EVs in the Heart
Heart function is based on a well-controlled communication system between different cell types. Although, EVs are well appreciated in the process of tumor and infection biology, research on cardiac EVs is increasing. So far no direct evidences for secretion of Wnt components on EVs from heart cells exist. Thus, we will integrate evidences from other fields, which may help to advances the knowledge on EVs/Wnt-mediated mechanisms in heart tissue.
In Heart Development and Tissue Regeneration
Wnt signaling is crucial for embryonic development and tissue regeneration (3, 35). Specifically in cardiogenesis, activation of the Wnt/β-catenin signaling induces mesodermal formation, cardiac progenitor cell specification and maintenance, but inhibits further differentiation towards cardiomyocytes (36). Ectopic inactivation of the Wnt/β-catenin signaling in a tissue other than cardiac mesoderm, such as endoderm, is sufficient to trigger differentiation towards cardiac cells, indicating the central role of Wnt in cardiac cell formation (37). Several Wnt ligands are expressed in the early heart including Wnt2, Wnt2b, Wnt11, and Wnt8a, indicating the participation of canonical and non-canonical branches (38). Indeed, initial activation of Wnt/β-catenin signaling is followed by an activation of the Wnt/β-catenin-independent pathway, which represses the canonical signaling and regulates cell processes (39). Moreover, Wnt5a and Wnt11 promote cardiac differentiation in embryonic and adult stem cells through non-canonical pathways and may be necessary to balance β-catenin-dependent proliferation in the outflow tract (38, 40, 41). Hence, Wnt signaling is a network of inter-linked branches engaging different cell populations into intercellular crosstalk. Further details of the role of Wnt signals during cardiogenesis are extensively described elsewhere (36).
Notably, heart regeneration mechanisms vary among species. In contrast to the limited injury-induced regeneration in early stages of life in adult mammal hearts, lower vertebrate like amphibian and teleost fish have sufficient regenerative capacity upon injury mainly by dedifferentiation of cardiomyocytes (35). In mouse, Wnt signaling exerts a similar role on adult cardiac progenitor cell (CPC) homoeostasis as observed during embryogenesis. Wnt/β-catenin activation impairs cardiomyocytes lineage differentiation and enhances endothelial cell (ECs) expansion, whereas its inactivation increases cardiomyocytes and reduced EC lineages (42–44). Accordingly, intra-myocardial injection of Wnt3a post-ischemia reduces CPC differentiation into cardiomyocytes (45). However, the role of Wnt signaling and most importantly the intercellular crosstalk in endogenous regeneration remains unclear. Interestingly, in the regenerative zebrafish hearts Wnt/β-catenin pathway is reactivated upon injury (35). In a recent study, one-day postnatal murine cardiomyocytes, with high regenerative potential, showed enriched Wnt signaling gene networks after ischemic injury (46). Since Wnt signaling becomes inactivated in the postnatal heart during later stages, it was speculated that reactivation of the signaling will confer regenerative capacity to the adult heart, however with impaired cardiac performance. This may imply an initial protective mechanism of the stressed heart to preserve cardiomyocytes function, which eventually fails upon sustained activation of the pathway (Figure 1), probably due to a low developmentally permissive transcriptional state of the adult cardiomyocytes (46).
Figure 1. Wnt activity is necessary for heart development and becomes very low in the adult heart. Upon stress, Wnt signaling components are upregulated in different heart cells. Transcriptional dependent-canonical Wnt signaling is known to be activated in CPCs, epicardial-derived cells (EPDCs), fibroblasts (FBs), cardiomyocytes (CMs), endothelial (EC) and smooth muscle cells (35, 47, 48). Non-canonical Wnt components are mainly upregulated in Macrophages (MΦ) and FBs. Wnt1 secretion from EPDCs and FB promotes FB expansion and fibrosis (48); Wnt5a secretion from FB promotes CM-hypertrophy and fibrosis (49, 50); Wnt5a secretion from macrophages (MΦ) induces inflammation and insulin resistance leading to cardiovascular complications (49, 51). Secreted frizzled-related protein 5 (Sfrp5) by healthy adipocytes inhibits Wnt5a function from MΦ. The presence of unhealthy adipocytes with reduced Sfrp5 secretion increased Wnt5a activity (52, 53). Wnt10b from healthy adipocytes balances adipocytes growth (54). CMs-secreted Wnt Inhibitory Factor 1 (WIF1) reduces Wnt5a activity and may affect CPCs proliferation (55). Secreted Wnt1, Wnt3a, Wnt5a as well as activation of Wnt/β-catenin induced by CPCs stimulate angiogenesis (48). Exosomes derived from cardiomyocytes (CMs) showed ability to reprogram fibroblasts (FBs) in vitro (56, 57). MiR-233 upregulates Wnt5a expression and miR-223 can be found in exosomes (58), thus Wnt5a regulation in cardiac failure may involve exosomal trafficking. Exosomes derived from adipocyte-derived mesenchymal stem cells (MSCs) was shown to activate Wnt/β-catenin signaling pathway, which may affect CM survival and constrains adipogenesis (20). Exosomes derived from umbilical cord MSCs showed a pro-angiogenic effect by delivering Wnt4 and activating Wnt/β-catenin signaling in endothelial cells (ECs) (21). Exosomes secreted from human induced pluripotent cells (iPSCs) showed protective effects on ischemic myocardium (59).
The Stressed Heart: Specific Wnt Component Regulation
Lack of robust regenerative response, upon stress/injury in the adult mammalian heart, results in adaptive tissue remodeling to sustain cardiac output. This finally leads to heart failure development characterized by a switch towards fetal metabolism and re-expression/elevation of developmental genes (60), including genes of the Wnt signaling pathway (13). Therefore, Wnt/β-catenin signaling has been considered a potentially therapeutic target for heart disease (35, 61–64). In the healthy adult heart, Wnt signaling is quiescent but becomes reactivated in different cell types in the ischemic and hypertrophic heart (Figure 1) (62–65). Specifically, Wnt/β-catenin activation is found in epicardium, fibroblasts, ECs, smooth muscle cells and CPCs (35) and in cardiomyocytes of the human failing heart (47). Conversely, Wnt inhibition appears to protect the heart from pathological ventricular remodeling (61, 63, 66, 67).
Recent studies indicate that the exosomal content is highly regulated in the heart by various stress conditions and that cardiomyocytes and cardiac fibroblasts release exosomes in in vitro studies (56, 68, 69). Moreover, Wnt ligands, FZDs and SFRPs are elevated after ischemic heart injury (48). These observations allow speculating that Wnts traveling on exosomes upon cardiac remodeling may be part of the maladaptive response. After myocardial infarction (MI), cardiac fibroblasts respond to Wnt1 in an autocrine fashion to induce proliferation and fibrogenic genes expression (48). Wnt1, Wnt3a, and Wnt5a regulate proliferation and migration of ECs. Moreover, after MI, β-catenin accumulates in ECs of the rat heart, which suggests activation of canonical Wnt signaling (48). Accordingly, antagonizing Wnt3a/Wnt5a binding to its receptors FZDs prevents heart failure upon ischemia (61). Wnt3a and Wnt5a were already found in exosomes (10, 26, 28). Interestingly, cell-autonomous regulation of Wnt signaling by enhancing β-catenin export on exosomes and reducing its cellular pool was described in tumor cells (70). An exciting idea will be to stimulate exosomal export of β-catenin, thereby reducing signaling activity in heart remodeling and preventing heart failure development.
Upon MI, macrophages are a source of non-canonical Wnts. Genetic ablation of Wnt signaling in mice results in macrophages with anti-inflammatory, reparative, and angiogenic properties and improved left ventricular function and remodeling after MI, possibly by the elimination of non-canonical signaling (51). In the failing myocardium, Wnt5a was most prominently upregulated in cardiac fibroblasts and elevated circulating Wnt5a levels were associated with adverse outcomes in patients with dilated cardiomyopathies (49). In mouse and human cardiac fibroblasts, recombinant Wnt5a upregulated the release of Interleukine (IL)-6 and Tissue Inhibitor Of Metalloproteinases 1 (TIMP-1). This might promote myocardial inflammation and fibrosis contributing to heart failure progression (50). Moreover, Wnt5a is known to stimulate hypertrophy in cultured cardiomyocytes (49). Increasing evidence suggests that miR-223 upregulates Wnt5a expression (50) and miR-223 can be found in exosomes (58), hence Wnt5a regulation in cardiac failure may involve exosomal trafficking.
Upon MI, Secreted frizzled-related protein 5 (Sfrp5) functions as an extracellular inhibitor of non-canonical Wnt signaling (52) that antagonizes the pro-inflammatory activity of Wnt5a. Sfrp5 is highly expressed by healthy adipocytes, thus may act as a paracrine cardio-protective adipokine. Obese people with “unhealthy adipocytes” with reduced expression of Sfrp5 and high Wnt5a have an associated insulin resistance with a high risk of cardiovascular complications (53). Moreover, Wnt5a overexpression in myeloid cells augments adipose tissue inflammation; promotes pro-inflammatory cytokines by macrophages and impairs glucose homeostasis (54). Accordingly, Wnt5a ablation in obese mice ameliorates insulin resistance. Thus, Wnt5a crucially mediates cellular crosstalk to finally affect glucose metabolism and cardiac homeostasis. Additionally, Wnt5a induced hypertrophic NFAT activation in cardiomyocytes in vitro (49). Another Wnt, Wnt10b constrains mouse white adipose tissue expansion by inhibiting pre-adipocyte differentiation, modifying adipokine secretion and immune-modulatory roles of fat tissue (54). Of note, adipose tissue is an important source of circulating exosomal miRNAs in mice and humans and may regulate whole-body metabolism (71). Exosomes derived from adipocyte-derived mesenchymal stem cells (ADMSCs-ex) significantly ameliorated ischemia/reperfusion-induced myocardial necrosis and apoptosis in rat heart (20). The mechanisms underlying the cardioprotective effects of ADMSCs-ex may be associated with activation of Wnt/β-catenin signaling, a critical regulator of survival and apoptosis of cardiomyocytes (Figure 1B).
Hypoxic cardiomyocytes upregulate Wnt Inhibitory Factor 1 (WIF1) (72), which interferes with non-canonical Wnt signaling in monocytes and macrophages and reduces pro-inflammatory activation upon ischemia. In patients with hypoxia-associated disorders such as MI, stroke and pre-eclampsia, an increase of circulating EVs indicates a role of EVs as biomarkers in these pathophysiological states (55). EVs could be regarded as radar signals that confer a population overall fitness and unify their individual regulatory patterns.
Taken together, Wnt signaling activation is key in pathological heart remodeling and EV-mediated signaling may participate in this activation. The contribution of EV-mediated Wnt signaling to block tissue regeneration needs further investigation in order to engineer EV-modifications allowing the recovery of developmental plasticity.
EV-Signaling in Cardiovascular Cells
Proper cardiac function relies on communication of cardiomyocytes with other cell types including smooth muscle cells, EC, fibroblasts and immune cells (73). These cells function together by interacting physically or via secreted factors, including lipids, peptide, nucleotides and miRNAs. The adult myocardium secretes exosomes to mediate cell-cell communication (74). Upon cardiac stress, fibroblast-secreted exosomes enriched in miR-21*, which is normally degraded, is taken up by cardiomyocytes to induce cell hypertrophy (69). Moreover, during MI, distinct exosome-contents from border zone and healthy heart cells suggest an adaptive response to injury defined by exosome secretion (75). Primary cardiomyocytes were capable of secreting EVs with the ability to reprogram fibroblasts in vitro (56, 57). Thus, cardiomyocytes are able to transfer signals to direct neighboring cell fate (Figure 1B). Exosomes are not only potential circulating biomarkers (76) but they are also considered for their potential therapeutic anti-fibrotic and angiogenetic effects as antioxidants protecting cardiomyocytes (77).
Exosome-Mediated Signaling in Endogenous Progenitors
Current data indicate a role for Wnt signaling in the homeostasis of CPCs in the adult heart. However, cardiac functionality may not be directly affected by changing the balance of this small pool but by secreted products (78). In line with this, stem cell injections in the adult heart were suggested to mediate a paracrine regeneration through secreted signals (72) and CPCs are a source of exosomes (79). Under hypoxia conditions, these cells secrete “pro-regenerative” exosomes inducing proliferation of ECs (73). Cardiomyocyte progenitor and mesenchymal stem cell-exosomes have powerful pro-angiogenic effects (80) (Figure 1B). Given, the above-discussed action of Wnt activation on stimulating ECs fate, it is tempting to speculate that those “endothelial-pro-regenerative” exosomes may signal through the Wnt pathway.
Since exosomes are carriers of both protective and pathological signals, a better understanding of their content and effect on recipient cell will help to define therapeutic utilities of EVs. And will broaden our understanding of how cells and organs communicate among each other (73).
Regenerative Potential of EVs
Tissue repair requires not only the presence of cells capable to restore damage tissue, but more importantly, requires a microenvironment promoting tissue regeneration. A recent study showed that fibroblast-derived exosomes relocalize Wnt10b into lipid rafts, activating mTOR and promoting axonal regeneration in an inhibitory environment after optic nerve injury (30). It seems that Wnts on different EVs have similar signaling capacities and that loading with specific content is more relevant for their functionality than the EVs used to mobilize (28). This is in agreement with biotechnological approaches where liposomal packaging of Wnts confers a longer stability and high signaling capacity in regeneration models (81, 82). This microenvironment can be created by exosomes with defined contents, ideally delivering signals affecting cell recruitment, differentiation and immunomodulation. Given the important role of exosomes in tissue regeneration in pre-clinical models, further studies addressing the EVs-mediated signaling are of high interest. Elucidating these mechanisms will offer a great platform for EVs engineering for personalized medicine.
Human pluripotent stem cells (hPSCs) and induced pluripotent cells (iPSCs) have been widely used in translational medicine for their enormous therapeutic potential in tissue repair and regeneration. Isolated exosomes secreted from iPSCs showed protective effects on ischemic myocardium by transferring the endogenous molecules to salvage the injured neighboring cells (59). In this regard, iPSCs-derived exosomes could be used for clinical application as autologous bioactive, cardio-protective exosomes to treat heart diseases and become a clinical tool for personalized medicine (75). Exosomes derived from umbilical cord mesenchymal stem cells showed a pro-angiogenic effect by delivering Wnt4 and activating Wnt/β-catenin signaling in ECs (21). Since activation of Wnt/β-catenin signaling is also pro-angiogenic in the adult heart, it is tempting to speculate that endogenous CPCs may also use EVs for pro-angiogenic signaling. Activation of canonical Wnt signaling was also reported in osteoblast-derived exosomes carrying miRNA to promote osteogenic differentiation. Thus, not only Wnt components may be carried onto EVs but also miRNA regulating Wnt signaling may be involved in cell-cell communication.
Cell therapies can directly support regenerative processes by forming new functional tissues or supporting tissue generation via paracrine mechanisms. Dissecting the precise role of Wnt signaling in cardiac tissue regeneration and the potential use of synthetic EVs may help tailor therapeutic approaches aiming to restore tissue functionality in a non-regenerative environment such as the heart. Moreover, human PSCs provide an excellent tool to address EV-mediated signaling in the context of early cardiogenesis. Developing protocols for exosomes isolation in their in vivo environment will allow cell-type and cargo-specific EVs and will enormously advance the field of EV-mediated signaling.
Conclusion
Modulation of Wnt signaling is crucial for tissue homeostasis in the developing and postnatal heart. However, the role of Wnt/β-catenin-dependent and -independent pathways in the intercellular crosstalk of heart cells is not fully understood. Activating or inactivating branches of the Wnt-network in specific target cells may be attractive to modulate pathological processes in the cardiovascular system or to enhance regenerative capacities of stem cell therapies. Many of these mechanisms might be mediated by EVs. Hence, understanding Wnt signal transduction via EVs between cell populations and tissues will advance our strategies for therapeutic modulation of these pathways.
Author Contributions
Both authors conceived, discussed and wrote the review.
Funding
Research in the lab of JCG is supported by the DFG-funded Research Center SFB1324/1 and GR4810/2-1. Research in the lab of LCZ is funded by DFGZE900-3; SFB 1002 Project C07 and the German Center for Cardiovascular Disease (DZHK). We acknowledge support by the Open Access Publication Funds of the Göttingen University
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The reviewer PY and handling Editor declared their shared affiliation.
Acknowledgement
We specially thank Lavanya M. Iyer for revising the manuscript. We apologize to all those colleagues whose important work is not cited because of space considerations.
References
1. Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol (2012) 13(12):767–79. doi: 10.1038/nrm3470
2. Simons M, Mlodzik M. Planar cell polarity signaling: from fly development to human disease. Annu. Rev. Genet. (2008) 42(1):517–40.
3. van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development (2009) 136(19):3205–14. doi: 10.1242/dev.033910
4. Cruciat CM, Niehrs C. Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb Perspect Biol (2013) 5(3):a015081. doi: 10.1101/cshperspect.a015081
5. Gross JC, Boutros M. Secretion and extracellular space travel of Wnt proteins. Curr Opin Genet Dev (2013) 23(4):385–90. doi: 10.1016/j.gde.2013.02.017
6. Panáková D, Sprong H, Marois E, Thiele C, Eaton S. Lipoprotein particles are required for Hedgehog and Wingless signalling. Nature (2005) 435(7038):58–65. doi: 10.1038/nature03504
7. Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, Ehlers S, et al. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. Faseb J (2010) 24(11):4599–612. doi: 10.1096/fj.10-160994
8. Huang H, Kornberg TB. Myoblast cytonemes mediate Wg signaling from the wing imaginal disc and Delta-Notch signaling to the air sac primordium. Elife (2015) 4:e06114. doi: 10.7554/eLife.06114
9. Stanganello E, Hagemann AI, Mattes B, Sinner C, Meyen D, Weber S, et al. Filopodia-based Wnt transport during vertebrate tissue patterning. Nat Commun (2015) 6:5846. doi: 10.1038/ncomms6846
10. Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active Wnt proteins are secreted on exosomes. Nat Cell Biol (2012) 14(10):1036–45. doi: 10.1038/ncb2574
11. Mcgough IJ, Vincent JP. Exosomes in developmental signalling. Development (2016) 143(14):2482–93. doi: 10.1242/dev.126516
12. Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 4:27066. doi: 10.3402/jev.v4.27066
13. Menck K, Sönmezer C, Worst TS, Schulz M, Dihazi GH, Streit F, et al. Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane. J Extracell Vesicles (2017) 6(1):1378056. doi: 10.1080/20013078.2017.1378056
14. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA (2016) 113(8):E968–E977. doi: 10.1073/pnas.1521230113
15. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol (2012) 14(7):677–85. doi: 10.1038/ncb2502
16. Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, et al. Methodological guidelines to study extracellular vesicles. Circ Res (2017) 120(10):1632–48. doi: 10.1161/CIRCRESAHA.117.309417
17. Zhang L, Wrana JL. The emerging role of exosomes in Wnt secretion and transport. Curr Opin Genet Dev (2014) 27:14–19. doi: 10.1016/j.gde.2014.03.006
18. Koch R, Demant M, Aung T, Diering N, Cicholas A, Chapuy B, et al. Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma. Blood (2014) 123(14):2189–98. doi: 10.1182/blood-2013-08-523886
19. Koch S, Acebron SP, Herbst J, Hatiboglu G, Niehrs C. Post-transcriptional Wnt signaling governs epididymal sperm maturation. Cell (2015) 163(5):1225–36. doi: 10.1016/j.cell.2015.10.029
20. Cui X, He Z, Liang Z, Chen Z, Wang H, Zhang J. Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway. J Cardiovasc Pharmacol (2017) 70(4):225–31. doi: 10.1097/FJC.0000000000000507
21. Zhang B, Wu X, Zhang X, Sun Y, Yan Y, Shi H, et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway. Stem Cells Transl Med (2015) 4(5):513–22. doi: 10.5966/sctm.2014-0267
22. Zhang B, Wang M, Gong A, Zhang X, Wu X, Zhu Y, et al. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells (2015) 33(7):2158–68. doi: 10.1002/stem.1771
23. Huang Z, Feng Y. Exosomes Derived From Hypoxic Colorectal Cancer Cells Promote Angiogenesis Through Wnt4-Induced β-Catenin Signaling in Endothelial Cells. Oncol. Res. (2017) 25(5):651–61.
24. Shi H, Xu X, Zhang B, Xu J, Pan Z, Gong A, et al. 3,3'-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing. Theranostics (2017) 7(6):1674–88. doi: 10.7150/thno.18082
25. Chen Q, Takada R, Noda C, Kobayashi S, Takada S. Different populations of Wnt-containing vesicles are individually released from polarized epithelial cells. Sci Rep (2016) 6:35562. doi: 10.1038/srep35562
26. Harada T, Yamamoto H, Kishida S, Kishida M, Awada C, Takao T, et al. Wnt5b-associated exosomes promote cancer cell migration and proliferation. Cancer Sci (2017) 108(1):42–52. doi: 10.1111/cas.13109
27. Chen Y, Zeng C, Zhan Y, Wang H, Jiang X, Li W. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b. Oncogene (2017) 36(33):4692–705. doi: 10.1038/onc.2017.100
28. Menck K, Klemm F, Gross JC, Pukrop T, Wenzel D, Binder C. Induction and transport of Wnt 5a during macrophage-induced malignant invasion is mediated by two types of extracellular vesicles. Oncotarget (2013) 4(11):2057–66. doi: 10.18632/oncotarget.1336
29. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell (2012) 151(7):1542–56. doi: 10.1016/j.cell.2012.11.024
30. Tassew NG, Charish J, Shabanzadeh AP, Luga V, Harada H, Farhani N, et al. Exosomes mediate mobilization of autocrine Wnt10b to promote axonal regeneration in the injured CNS. Cell Rep (2017) 20(1):99–111. doi: 10.1016/j.celrep.2017.06.009
31. Korkut C, Ataman B, Ramachandran P, Ashley J, Barria R, Gherbesi N, et al. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell (2009) 139(2):393–404. doi: 10.1016/j.cell.2009.07.051
32. Koles K, Nunnari J, Korkut C, Barria R, Brewer C, Li Y, et al. Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons. J Biol Chem (2012) 287(20):16820–34. doi: 10.1074/jbc.M112.342667
33. Jiang N, Xiang L, He L, Yang G, Zheng J, Wang C, et al. Exosomes Mediate Epithelium-Mesenchyme Crosstalk in Organ Development. ACS Nano (2017) 11(8):7736–46.
34. Luga V, Wrana JL. Tumor-stroma interaction: Revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis. Cancer Res (2013) 73(23):6843–7. doi: 10.1158/0008-5472.CAN-13-1791
35. Ozhan G, Weidinger G. Wnt/β-catenin signaling in heart regeneration. Cell Regen (2015) 4(1):3. doi: 10.1186/s13619-015-0017-8
36. Gessert S, Kühl M. The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ Res (2010) 107(2):186–99. doi: 10.1161/CIRCRESAHA.110.221531
37. Lickert H, Kutsch S, Kanzler B, Tamai Y, Taketo MM, Kemler R. Formation of multiple hearts in mice following deletion of beta-catenin in the embryonic endoderm. Dev Cell (2002) 3(2):171–81. doi: 10.1016/S1534-5807(02)00206-X
38. Tian Y, Cohen ED, Morrisey EE. The importance of Wnt signaling in cardiovascular development. Pediatr Cardiol (2010) 31(3):342–8. doi: 10.1007/s00246-009-9606-z
39. Cohen ED, Tian Y, Morrisey EE. Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development (2008) 135(5):789–98. doi: 10.1242/dev.016865
40. Mehta A, Ramachandra CJ, Sequiera GL, Sudibyo Y, Nandihalli M, Yong PJ, et al. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochim Biophys Acta (2014) 1843(11):2394–402. doi: 10.1016/j.bbamcr.2014.06.011
41. Cohen ED, Miller MF, Wang Z, Moon RT, Morrisey EE. Wnt5a and Wnt11 are essential for second heart field progenitor development. Development (2012) 139(11):1931–40. doi: 10.1242/dev.069377
42. Noack C, Zafiriou MP, Schaeffer HJ, Renger A, Pavlova E, Dietz R, et al. Krueppel-like factor 15 regulates Wnt/β-catenin transcription and controls cardiac progenitor cell fate in the postnatal heart. EMBO Mol Med (2012) 4(9):992–1007. doi: 10.1002/emmm.201101043
43. Zelarayán LC, Noack C, Sekkali B, Kmecova J, Gehrke C, Renger A, et al. Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci USA (2008) 105(50):19762–7. doi: 10.1073/pnas.0808393105
44. Klaus A, Saga Y, Taketo MM, Tzahor E, Birchmeier W. Distinct roles of Wnt/beta-catenin and Bmp signaling during early cardiogenesis. Proc Natl Acad Sci USA (2007) 104(47):18531–6. doi: 10.1073/pnas.0703113104
45. Oikonomopoulos A, Sereti KI, Conyers F, Bauer M, Liao A, Guan J, et al. Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res (2011) 109(12):1363–74. doi: 10.1161/CIRCRESAHA.111.250282
46. Quaife-Ryan GA, Sim CB, Ziemann M, Kaspi A, Rafehi H, Ramialison M, et al. Multicellular transcriptional analysis of mammalian heart regeneration. Circulation (2017) 136(12):1123–39. doi: 10.1161/CIRCULATIONAHA.117.028252
47. Hou N, Ye B, Li X, Margulies KB, Xu H, Wang X, et al. Transcription Factor 7-like 2 mediates canonical Wnt/β-catenin signaling and c-Myc upregulation in heart failure. Circ Heart Fail (2016) 9(6):e003010. doi: 10.1161/CIRCHEARTFAILURE.116.003010
48. Deb A. Cell-cell interaction in the heart via Wnt/β-catenin pathway after cardiac injury. Cardiovasc Res (2014) 102(2):214–23. doi: 10.1093/cvr/cvu054
49. Abraityte A, Lunde IG, Askevold ET, Michelsen AE, Christensen G, Aukrust P, et al. Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy. Sci Rep (2017) 7(1):3490. doi: 10.1038/s41598-017-03625-9
50. Abraityte A, Vinge LE, Askevold ET, Lekva T, Michelsen AE, Ranheim T, et al. Wnt5a is elevated in heart failure and affects cardiac fibroblast function. J Mol Med (2017) 95(7):767–77. doi: 10.1007/s00109-017-1529-1
51. Palevski D, Levin-Kotler LP, Kain D, Naftali-Shani N, Landa N, Ben-Mordechai T, et al. Loss of macrophage Wnt secretion improves remodeling and function after myocardial infarction in mice. J Am Heart Assoc (2017) 6(1):e004387. doi: 10.1161/JAHA.116.004387
52. Nakamura K, Sano S, Fuster JJ, Kikuchi R, Shimizu I, Ohshima K, et al. Secreted frizzled-related protein 5 diminishes cardiac inflammation and protects the heart from ischemia/reperfusion injury. J Biol Chem (2016) 291(6):2566–75. doi: 10.1074/jbc.M115.693937
53. Fuster JJ, Zuriaga MA, Ngo DT, Farb MG, Aprahamian T, Yamaguchi TP, et al. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes (2015) 64(4):1235–48. doi: 10.2337/db14-1164
54. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. Adipogenesis and WNT signalling. Trends Endocrinol Metab (2009) 20(1):16–24. doi: 10.1016/j.tem.2008.09.002
55. Belting M, Christianson HC. Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease. J Intern Med (2015) 278(3):251–63. doi: 10.1111/joim.12393
56. Waldenström A, Gennebäck N, Hellman U, Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One (2012) 7(4):e34653. doi: 10.1371/journal.pone.0034653
57. Malik ZA, Kott KS, Poe AJ, Kuo T, Chen L, Ferrara KW, et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol (2013) 304(7):H954:H954–H965. doi: 10.1152/ajpheart.00835.2012
58. Wang X, Gu H, Qin D, Yang L, Huang W, Essandoh K, et al. Exosomal miR-223 contributes to mesenchymal stem cell-elicited cardioprotection in polymicrobial sepsis. Sci Rep (2015) 5:13721. doi: 10.1038/srep13721
59. Wang Y, Zhang L, Li Y, Chen L, Wang X, Guo W, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol (2015) 192:61–9. doi: 10.1016/j.ijcard.2015.05.020
60. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. (2003) 65(1):45–79.
61. Dawson K, Aflaki M, Nattel S. Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. J Physiol (2013) 591(6):1409–32. doi: 10.1113/jphysiol.2012.235382
62. Hermans KC, Blankesteijn WM. Wnt Signaling in Cardiac Disease. Compr Physiol (2015) 5(3):1183–209. doi: 10.1002/cphy.c140060
63. van de Schans VA, Smits JF, Blankesteijn WM. The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe? Eur J Pharmacol (2008) 585(2-3):338–45. doi: 10.1016/j.ejphar.2008.02.093
64. Nakagawa A, Naito AT, Sumida T, Nomura S, Shibamoto M, Higo T, et al. Activation of endothelial β-catenin signaling induces heart failure. Sci Rep (2016) 6:25009. doi: 10.1038/srep25009
65. Iyer LM, Nagarajan S, Woelfer M, Schoger E, Khadjeh S, Zafiriou MP, et al. A context-specific cardiac β-catenin and GATA4 interaction influences TCF7L2 occupancy and remodels chromatin driving disease progression in the adult heart. Nucleic Acids Res. (2018):gky049. doi: 10.1093/nar/gky049
66. Xiang FL, Fang M, Yutzey KE. Loss of β-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice. Nat Commun (2017) 8(1):712. doi: 10.1038/s41467-017-00840-w
67. van de Schans VA, van den Borne SW, Strzelecka AE, Janssen BJ, van der Velden JL, Langen RC, et al. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy. Hypertension (2007) 49(3):473–80. doi: 10.1161/01.HYP.0000255946.55091.24
68. Ailawadi S, Wang X, Gu H, Fan GC. Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta (2015) 1852(1):1–11. doi: 10.1016/j.bbadis.2014.10.008
69. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest (2014) 124(5):2136–46. doi: 10.1172/JCI70577
70. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol (2010) 190(6):1079–91. doi: 10.1083/jcb.201002049
71. Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature (2017) 542(7642):450–5. doi: 10.1038/nature21365
72. Meyer IS, Jungmann A, Dieterich C, Zhang M, Lasitschka F, Werkmeister S, et al. The cardiac microenvironment uses non-canonical WNT signaling to activate monocytes after myocardial infarction. EMBO Mol Med (2017) 9(9):1279–93. doi: 10.15252/emmm.201707565
73. Ottaviani L, de Windt LJ, da Costa Martins PA. Exosomes: scytales in the damaged heart. Ann Transl Med (2016) 4(11):222. doi: 10.21037/atm.2016.05.17
74. Barile L, Gherghiceanu M, Popescu LM, Moccetti T, Vassalli G. Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres. J Biomed Biotechnol (2012) 2012:354605:1–10. doi: 10.1155/2012/354605
75. Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res (2014) 103(4):530–41. doi: 10.1093/cvr/cvu167
76. Jung JH, Fu X, Yang PC. Exosomes generated from iPSC-Derivatives: new direction for stem cell therapy in human heart diseases. Circ Res (2017) 120(2):407–17. doi: 10.1161/CIRCRESAHA.116.309307
77. Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res (2015) 116(2):255–63. doi: 10.1161/CIRCRESAHA.116.304360
78. de Jong OG, van Balkom BW, Schiffelers RM, Bouten CV, Verhaar MC. Extracellular vesicles: potential roles in regenerative medicine. Front Immunol (2014) 5:608. doi: 10.3389/fimmu.2014.00608
79. Chistiakov DA, Orekhov AN, Bobryshev YV. Cardiac extracellular vesicles in normal and infarcted heart. Int J Mol Sci (2016) 17(1):63. doi: 10.3390/ijms17010063
80. Vrijsen KR, Maring JA, Chamuleau SA, Verhage V, Mol EA, Deddens JC, et al. Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv Healthc Mater (2016) 5(19):2555–65. doi: 10.1002/adhm.201600308
81. Tüysüz N, van Bloois L, van den Brink S, Begthel H, Verstegen MM, Cruz LJ, et al. Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells. Nat Commun (2017) 8:14578. doi: 10.1038/ncomms14578
Keywords: extracellular vesicles, exosomes, Wnt signaling, Wnt secretion, heart remodeling
Citation: Gross JC and Zelarayán LC (2018). The Mingle-Mangle of Wnt Signaling and Extracellular Vesicles: Functional Implications for Heart Research. Front. Cardiovasc. Med. 5:10. doi: 10.3389/fcvm.2018.00010
Received: 01 September 2017; Accepted: 29 January 2018;
Published: 22 February 2018
Edited by:
Elena Aikawa, Brigham and Women's Hospital, United StatesReviewed by:
Paul B. Yu, Brigham and Women's Hospital, United StatesJose Javier Fuster, Boston University, United States
Copyright © 2018 Gross and Zelarayán. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Julia Christina Gross, julia.gross@med.uni-goettingen.de; Laura Cecilia Zelarayán, laura.zelarayan@med.uni-goettingen.de